Free article Directory Tough RegisterBusiness article directory

Our organization is an independent Contract Research Organization based in the U.S. that conducts preclinical medicine trials in state-of-the art, GLP certified research facilities in Kiev, Ukraine. Our research facilities are supported by the Ukrainian National Academy of Medical Sciences and Health Department and offer support for commercial development of new medicine discoveries as part of their main purpose. Our business was founded to bring the high quality, lower cost services of these facilities to start-up bio-technology companies in the United States and EU, thereby offering a smart option for promoting development programs quickly and at much lower cost than other commercial CROs. We provide a wide range of pre-clinical Contract Research Organization including drug safety, chronic and acute toxicity, pharma screening, bio-availability , bioequivalence, and extensive in vivo and in vitro screening for anticancer activity.

Our preclinical Contract Research Organization is able to price preclinical trials far below other CROs since we maintain a very low overhead in the U.S. and perform all studies in Kiev, UA where personnel and laboratory costs are much lower. Our staff in the USA consists only of the company principals who deal directly with clients; we don’t have any marketing costs other than our web site, and no main offices, administrative staff or other overhead to inflate costs. We have much lower research conduct costs in Ukraine due to much lower personnel rates and are able to provide our best pricing for longer and more intricate preclinical tests where labor is the most significant part of the overall price. Because we use the same reliable international providers for lab animals, reagents and lab supplies as other CROs, we have no cost advantage on these items and thus less overall cost savings for very short-term preclinical tests. However, regardless of your trial protocol and duration, our goal is to provide our clients the greatest possible value for their investment.